Athira Pharma to Participate in Upcoming May Conferences
Athira Pharma, Inc. (ATHA)
Company Research
Source: GlobeNewswire
BOTHELL, Wash., May 02, 2024 (GLOBE NEWSWIRE) -- Athira Pharma, Inc. (NASDAQ: ATHA), a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, today announced that Company management will participate in the following upcoming investor conferences in May. Sidoti May 2024 Virtual Investor ConferenceFormat: Company PresentationDate and Time: Wednesday, May 8, 2024, from 10:45 a.m. - 11:15 a.m. ET Location: Virtual The Citizens JMP Life Sciences ConferenceFormat: Fireside Chat Date and Time: Monday, May 13, 2024, from 1:30 p.m. - 1:55 p.m. ET Location: New York Hilton Midtown Live webcasts of the panel and presentations can be accessed from the Investors section of the Athira website at https://investors.athira.com/news-and-events/events-and-presentations-investor. An archived replay of the webcasts will be available for at least 30 days following the event. About Athira Pharma, Inc.Athira Pharma, Inc
Show less
Read more
Impact Snapshot
Event Time:
ATHA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ATHA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ATHA alerts
High impacting Athira Pharma, Inc. news events
Weekly update
A roundup of the hottest topics
ATHA
News
- Athira Pharma, Inc. (NASDAQ: ATHA) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $19.00 price target on the stock.MarketBeat
- Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business Updates [Yahoo! Finance]Yahoo! Finance
- Athira Pharma Reports First Quarter 2024 Financial Results and Pipeline and Business UpdatesGlobeNewswire
- Athira Pharma to Participate in Upcoming May Conferences [Yahoo! Finance]Yahoo! Finance
- One Athira Pharma Insider Raised Their Stake In The Previous Year [Yahoo! Finance]Yahoo! Finance
ATHA
Earnings
- 5/15/24 - Beat
ATHA
Sec Filings
- 5/15/24 - Form 10-Q
- 5/15/24 - Form 8-K
- 4/16/24 - Form 4
- ATHA's page on the SEC website